Enveric Biosciences Inc expected to post a loss of $1.28 a share - Earnings Preview

Enveric Biosciences

27/03/2024 20:03

* Enveric Biosciences Inc  ENVB.OQ   ENVB.O  is expected
to report
resultson May 13 (estimated) for the period ending March 31 2024
    * 
    * ​LSEG's mean analyst estimate for Enveric Biosciences Inc
is for
a loss of $1.28 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 2.8%
in the last three months. ​
    * Wall Street's median 12-month price target for Enveric
Biosciences Inc is $10.00​, above​ its last closing price
of $1.06. ​​​

This summary was machine generated March 27 at 20:03 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)